Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

4 juin 2026 | Anna Bawden Health and social affairs correspondent
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant (…)
 Site référencé:  The Guardian (Asia Pacific)

The Guardian (Asia Pacific) 

‘An equal and habitable world is possible’ : academics set out sweeping vision for planetary survival
4/06/2026
‘It’ll never be like that again’ : Sonny Rollins and Steve Schapiro on jazz’s golden age – in pictures
4/06/2026
‘I’m asking people to do a lot, but that’s what it means to be a human’ : Roberto dos Santos on directing the first straight-to-VHS movie in 20 years
4/06/2026
‘Happiness is not just about GDP’ : ambitious plan or utopia ?
4/06/2026
A good life for the 99% isn’t a pipe dream : it can be done. Here’s how
4/06/2026
The Traveller – an 18th century explorer far ahead of his time
4/06/2026